HOME ABOUT US PRINT PUBLICATIONS SUBSCRIPTIONS CONTACT US RSS
 
Welcome to FDAweb
Pay Per View
Search our 45,643 - story database FREE
 
Free Items
 Warning Letters
 FDA Notices
 FDA Calendar
 

 FDA Whistleblowers



    








 
     
 
Latest FDA Warning Letters
09/11/2007
 

Today FDA posted its latest batch of Warning Letters. They can be accessed in Adobe PDF format by clicking on the link following each letter.


Melanocorp, Inc. Hendersonville, TN (8/30). Unapproved new drug. Claims on www.melanocorp.com such as “Hormone shots help tanning, cut sun damage: study" and "Drug can induce tanning" indicate the product is intended for use to prevent, treat, or cure disease conditions, which make it an unapproved new drug, etc. (Melanotan II); FDCA 505(a) (2007-NOL-15) http://www.fda.gov/foi/warning_letters/s6491c.pdf

Ochsner Clinic Foundation New Orleans, LA (8/29). Inspected 6/5,7 and 11. Deviations from the regulations for human cells, tissues, and cellular and tissue-based products: Clinic failed to test a specimen from an anonymous or directed donor of reproductive cells or tissue to adequately and appropriately reduce the risk of transmission of relevant communicable disease agents of the genitourinary tract, including Chlamydia trachomatis and Neisseria gonorrhea. No documentation was found during the review of six anonymous oocyte donor files from 2006 and 2007 to substantiate a responsible person, either from the firm or from the oocyte donor organizations, had determined the donors to be eligible for donation. Clinic failed to collect a donor specimen for testing for relevant communicable diseases within 30 days before oocyte recovery or up to seven days after recovery, etc. (human cells, tissues, and cellular and tissue-based products); 21 CFR 1271.85(c), 1271.50(a), 1271.75(a), 1271.3(n), 1271.55(d)(1) &(3), 1271.47(a) & (b) (2007-NOL-14)

http://www.fda.gov/foi/warning_letters/s6498c.pdf

Wheaton Beauty Supply Wheaton, MD (8/27). Inspected 5/30. Misbranded: Firm sells plano lenses directly to consumers without requiring any evidence of proper fitting or other eye care professional involvement. FDA has determined that these lenses are marketed without labeling describing the risks associated with the wearing of such lenses. The lenses are being sold to retail establishments such as flea markets, gas stations, beauty shops, clothing stores, and beauty supply stores without requiring any evidence of proper fitting or other eye care professional involvement. The lenses distributed by your firm have been cleared by FDA for prescription use only and are exempt from the Act’s requirements that they bear adequate directions for use if they are sold with a prescription. (plano lenses); FDCA 502(f)(1) (#07200322)
http://www.fda.gov/foi/warning_letters/s6496c.pdf

 

 
 
 
Any copying or electronic transfer without written permission is strictly prohibited and will result
in termination of service and prosecution under the federal Copyright Act.
To gain permission to copy this article log on to http://www.copyright.com.

FERDIC INCORPORATED - P.O. Box 28, Camp Hill, PA 17001 | Phone: (717)731-1426 fax:(717)731-1427 Email: info@fdaweb.com